Related stories
CAPR Stock Rises After Deramiocel Cardiac Data Wins American Heart Association Award Ahead Of FDA Decision
Shares of Capricor Therapeutics (CAPR) rose about 8% on Monday after the company said that cardiac results from its HOPE-3 late-stage trial of Deramiocel in Duchenne muscular dystr
L impact | REGULATION | Nov 09, 2026, 08:13 PM UTC
US Sec. Of State Rubio On AI: We Need Industry-Led Partnerships, Not More Regulation And Unnecessary Red Tape
L impact | REGULATION | Nov 09, 2026, 03:44 PM UTC
US Sec. Of State Rubio: Discussed Hurdles Faced By US Firms In Europe With France’s Barrot
L impact | REGULATION | Nov 09, 2026, 03:38 PM UTC
US FDA Orders New Eye-Risk Warnings for Ozempic and Zepbound
The FDA said it is requiring new warnings after informing patients and healthcare providers of a potential increased risk of a serious eye condition associated with GLP-1 drugs use
M impact | REGULATION | Nov 09, 2026, 02:53 PM UTC
NHTSA Opens Probe Into 1.2 Million Ford Vehicles Over Airbag Burn Risk
The National Highway Traffic Safety Administration is investigating certain Ford vehicles following reports of burn injuries caused by airbag deployments. Its preliminary evaluatio
M impact | REGULATION | Nov 09, 2026, 12:57 PM UTC
FDA Rejects Novocure’s Optune Mya Application for Brain Metastases
Novocure said it received a “not approvable” letter from the FDA for its U.S. premarket application for Optune Mya, a treatment for brain metastases.
M impact | REGULATION | Nov 09, 2026, 12:46 PM UTC